Theme: De novo in Drug Delivery Systems

Pharmaceutica 2017

Glimpses Of Pharmaceutica 2016, Madrid, Spain

Pharmaceutica 2017

Sessions/Tracks

Conference Series LLC is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. After a successful conference of Pharmaceutica 2016Conference Series LLC is currently bringing forth "10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems"  (Pharmaceutica 2017) slated on March 13-15, 2017 at London, UK.

Pharmaceutica 2017 covers various aspects of Pre-Formulation & Formulation Aspects, Pharmacokinetics and Pharmacodynamics in Drugs, Drug Targeting and Design, Routes of Drug Delivery, Nanoparticulate Drug Delivery Systems, Nanotechnology in Drug Delivery, Pharmaceutical Nanotechnology, Smart Drug Delivery Systems, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Peptides and Protein Drug Delivery, Global Drug Delivery Policy, Entrepreneurs Investment Meet

Track-1:  Pre-Formulation & Formulation Aspects

Pharmaceutics is the study of relationships between preformulationpharmaceutical formulation, delivery, disposition and clinical response. The inherent instability nature of a new drug will alter its desired form into undesired form when presented in a suitable dosage form with the excipient/s upon storage. In early days this process was confined only for assessing few characteristics, but today this process is being considered as a formulation strategy and hence tremendous technological advancement has been achieved in this field which enables us to save time and money through planned management system and hence impacts Pharmaceutica 2017 to be a formulation conference. Use of glorious statistical software even based on artificial neural networking are made the task of preformulation and optimization process easier. Role of preformulation studies techniques like freeze drying aspects projects the event Pharmaceutica 2017 to pose as a freeze drying meeting in drug discoverydrug development plays major role in pharmaceutical formulation development and the studies will help in different dosage forms design. With the increasing number of novel and specialized compounds being developed, a "one size fits all" approach to drug formulation and delivery is no longer optimal, necessitating the consideration of formulations unique to each drug. NDDS conference will discuss on Early Approaches, Present Scenario and Future Prospects of Preformulation events. There are more than 1400 sustained or controlled release drugs have been approved all over the world. Pharmaceutical conferences discuss the state-of-art technology being applied and involve advances in formulation studies. 

Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of overall international pharmaceutical market. The utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.

Relevant Conferences:

14th Pharmaceutical Formulations Conference Aug 28-29, 2017 Brussels, Belgium; 9th Drug Formulation & Drug Design Congress October 19-21, 2017 Seoul, South Korea; Pharmaceutical Development Conference April 24-26, 2017 Dubai, UAE; Pharmaceutical Technology Conference April 24-26, 2017 Dubai, UAE; 13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; International Conference on Biotech Pharmaceuticals October 23-25, 2017 Paris, France; 3rd Annual Formulation & Drug Delivery Congress May 08-09 2017, London, UK; Bioanalytical and Formulation Summit September 12-13, 2017 Prague, Czech Republic; Preclinical Form & Formulation for Drug Discovery June 04-09, 2017 Stoweflake Conference Center Stowe, VT; 8th Global Drug Delivery & Formulation Summit March 27-29, 2017 Berlin, Germany.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-2Pharmacokinetics and Pharmacodynamics in Drugs

Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics include enhancing efficacy and decreasing toxicity of a patient’s drug therapy. The development of strong correlations between drug concentrations and their pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.

Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and adverse effects. The effect of a drug present at the site of action is determined by that drug’s binding with a receptor. Receptors may be present on neurons in the central nervous system (i.e., opiate receptors) to depress pain sensation, on cardiac muscle to affect the intensity of contraction, or even within bacteria to disrupt maintenance of the bacterial cell wall.

Relevant Conferences:

5th Pharmacology & Ethnopharmacology Conference March 23-25, 2017 Orlando, USA; 6th Cardiovascular Pharmacology Meet April 13-14, 2017 Dubai, UAE; 6th Cardiac Medications Conference April 13-14, 2017 Dubai, UAE; 8th World Congress on Pharmacology & Toxicology July 24-26, 2017 Melbourne, Australia; 7th Global Experts Meeting on Neuropharmacology; July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology August 07-09, 2017 Paris, France; Annual Drug Metabolism and Applied Pharmacokinetics Conference September 18-21, 2017 Wisconsin, USA; 13th European Congress of Clinical Pharmacology and Therapeutics June 24-27, 2017 Prague, Czech Republic; 14th Symposium on Pharmacokinetics and Drug Metabolism March 29-30, 2017 Gothenburg, Sweden.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-3: Drug Targeting and Design

The most fundamental goal in drug design is to predict whether a given molecule will bind to a target and if so how strongly. Molecular mechanics or molecular dynamics are most often used to predict the conformation of the small molecule and to model conformational changes in the biological target that may occur when the small molecule binds to it. The therapeutic response of a drug depends upon the interaction of drug molecules with cell on cell membrane related biological events at receptor sites in concentration dependent manner.

Selective and effective localization of the pharmacologically-active moiety at preidentified target(s) in therapeutic concentration, while restricting its access to non-target(s) normal cellular linings, thus minimizing toxic effects and maximizing the therapeutic index accounts from effective and efficient drug delivery.

Molecular mechanics methods may also be used to provide semi-quantitative prediction of the binding affinity. Also, knowledge-based scoring function may be used to provide binding affinity estimates. These methods use linear regression, machine learning, neural nets or other statistical techniques to derive predictive binding affinity equations by fitting experimental affinities to computationally derived interaction energies between the small molecule and the target.

Ideally, the computational method will be able to predict affinity before a compound is synthesized and hence in theory only one compound needs to be synthesized, saving enormous time and cost. The reality is that present computational methods are imperfect and provide, at best, only qualitatively accurate estimates of affinity. In practice it still takes several iterations of design, synthesis, and testing before an optimal drug is discovered. Computational methods have accelerated discovery by reducing the number of iterations required and have often provided novel structures.

Relevant Conferences:

5th Pharmacology & Ethnopharmacology Conference March 23-25, 2017 Orlando, USA; 6th Cardiovascular Pharmacology Meet April 13-14, 2017 Dubai, UAE; 6th Cardiac Medications Conference April 13-14, 2017 Dubai, UAE; 8th World Congress on Pharmacology & Toxicology July 24-26, 2017 Melbourne, Australia; 7th Global Experts Meeting on Neuropharmacology; July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology August 07-09, 2017 Paris, France; Annual Drug Metabolism and Applied Pharmacokinetics Conference September 18-21, 2017 Wisconsin, USA; 13th European Congress of Clinical Pharmacology and Therapeutics June 24-27, 2017 Prague, Czech Republic; 14th Symposium on Pharmacokinetics and Drug Metabolism March 29-30, 2017 Gothenburg, Sweden.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-4: Routes of Drug Delivery

A route of administration is the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration. Routes can also be classified based on where the target of action is. Action may be topical (local), enteral (system-wide effect, but delivered through the gastrointestinal tract), or parenteral (systemic action, but delivered by routes other than the GI tract).

Routes of administration are usually classified by application location (or exposition). The route or course the active substance takes from application location to the location where it has its target effect is usually rather a matter of pharmacokinetics (concerning the processes of uptake, distribution, and elimination of drugs). Nevertheless, some routes, especially the transdermal or transmucosal routes are commonly referred to routes of administration. The location of the target effect of active substances is usually rather a matter of pharmacodynamics (concerning e.g. the physiological effects of drugs). Furthermore, there is also a classification of routes of administration that basically distinguishes whether the effect is local (in "topical" administration) or systemic (in "enteral" or "parenteral" administration).

Relevant Conferences:

Nanomedicine Conference May 29-31, 2017 Osaka, Japan; Drug Delivery Conference May 29-31, 2017 Osaka, Japan; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA; 10th Biologics Conference October 16-17, 2017 Baltimore, USA; 10th Biosimilars Conference October 16-17, 2017 Baltimore, USA; 13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; 3rd Biopharmaceutics Conference June 19-20, 2017 Philadelphia, USA;  3rd Biologic Drugs Conference June 19-20, 2017 Philadelphia, USA; Partnerships in Drug Delivery October 19-20, 2017 MA, USA; International Symposium on Drug Delivery and Pharmaceutical Sciences March 09–10, 2017 Kyoto, Japan; Non-Invasive Delivery of Macromolecules Conference 2017 February 21-24 2017 Carlsbad, USA; 2nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (Nddte'17) April 4 - 6, 2017 Barcelona, Spain; 2nd European Conference on Pharmaceutics April 03-04, 2017 Krakow, Poland; Respiratory Drug Delivery 2017(RDD Europe 2017) April 25-28, 2017 Nice, France.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-5: Nanoparticulate Drug Delivery Systems

Nanoparticles (NPs) occur naturally and have been in existence for thousands of years as products of combustion and cooking of food. Nanomaterials differ significantly from other materials due to the following two major principal factors: the increased surface area and quantum effects. These factors can enhance properties such as reactivity, strength, electrical characteristics, and in vivo behaviour. As the particle size decreases, a greater proportion of atoms are found at the surface compared to inside. An NP has a much greater surface area per unit mass compared with larger particles, leading to greater reactivity. In tandem with surface area effects, quantum effects can begin to dominate the properties of matter as size is reduced to the nanoscale. These can affect the optical, electrical, and magnetic behaviour of materials. Their in vivo behaviour can be from increased absorption to high toxicity of nanomaterials. New drug carrier systems are one can name soluble polymers, microparticles made of insoluble (or) biodegradable natural and synthetic  polymers, microcapsules, cells, cell ghosts, lipoproteins, liposomes and micelles. Pharmaceutica 2017 evolves to be a drug disintegration conference, emulsion conference, capsule conference, and solubility conference. Pharmaceutical conferences will cover industry case studies, regulatory updates, latest therapies and technology innovations and much more. 

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group, and Peptisyntha Inc. at the pharmaceutical companies’ conference.

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Relevant Conferences:

13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; Pharmaceutical Development Conference April 24-26, 2017 Dubai, UAE; Pharmaceutical Technology Conference April 24-26, 2017 Dubai, UAE; Nanomedicine Conference May 29-31, 2017 Osaka, Japan; Drug Delivery Conference May 29-31, 2017 Osaka, Japan; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; Partnerships in Drug Delivery October 19-20, 2017 MA, USA; International Symposium on Drug Delivery and Pharmaceutical Sciences March 09–10, 2017 Kyoto, Japan; Non-Invasive Delivery of Macromolecules Conference 2017 February 21-24 2017 Carlsbad, USA; 2nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (Nddte'17) April 4 - 6, 2017 Barcelona, Spain; 2nd European Conference on Pharmaceutics April 03-04, 2017 Krakow, Poland; Respiratory Drug Delivery 2017(RDD Europe 2017) April 25-28, 2017 Nice, France.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-6: Nanotechnology in Drug Delivery

Nanotechnology has finally and firmly entered the realm of drug delivery. Performances of intelligent drug delivery systems are continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. The primary goals for research of nano-bio-technologies in drug delivery include:

  • More specific drug targeting and delivery,
  • Reduction in toxicity while maintaining therapeutic effects,
  • Greater safety and biocompatibility, and
  • Faster development of new safe medicines

Pharmaceutical conferences offers presentations by researchers from a number of disciplines, from the life sciences to engineering, who will address a range of topics including peptide and protein delivery, gene delivery, cell delivery, vaccines, transdermals, pulmonary delivery, new materials, and other subjects, from varied disciplines while focusing on the central theme of drug delivery.

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group, Peptisyntha Inc. and Lonza Inc.   

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Relevant Conferences:

14th Nanomaterials and Nanotechnology Conference March 30- 31, 2017 Madrid, Spain; 15th World Medical Nanotechnology Congress & Expo October 18-19, 2017 Osaka, Japan; Industrial Nanotechnology Conference September 18-19, 2017 Florida, USA; 13th Nanotek Conference and Expo December 05-07, 2016 Arizona, USA; 22nd Nanoscience Conference November 13-14, 2017 Vienna, Austria; Molecular Nanotechnology Conference November 13-14, 2017 Vienna, Austria; 20th Annual Nanotech 2017 Conference & Expo May 14-17, 2017 Washington, USA; 8th International Conference on Advanced Materials and Nanotechnology February 12-16, 2017 Queenstown, New Zealand; 5th International Conference on Multifunctional, Hybrid and Nanomaterials March 06-10, 2017; 17th International Conference on Nanotechnology July 25-28, 2017 Pittsburgh, PA; Nanotech France 2017 Conference and Exhibition June 28-30, 2017 Paris, France; 8th International Nanomedicine Conference July 03–05 2017 Sydney, Australia.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-7: Pharmaceutical Nanotechnology

Size reduction is a fundamental unit operation having important applications in pharmacy. It helps in improving solubility and bioavailability, reducing toxicity, enhancing release and providing better formulation opportunities for drugs. In most of the cases, size reduction is limited to micron size range, for example, various pharmaceutical dosage forms like powder, emulsion, suspension etc. Drugs in the nanometer size range enhance performance in a variety of dosage forms. Major advantages of nanosizing include (i) increased surface area, (ii) enhanced solubility, (iii) increased rate of dissolution, (iv) increased oral bioavailability, (v) more rapid onset of therapeutic action, (vi) less amount of dose required, (vii) decreased fed/fasted variability, and (viii) decreased patient-to-patient variability.

Pharmaceutical nanotechnology has provided more fine-tuned diagnosis and focused treatment of disease at a molecular level. Pharmaceutical nanotechnology is most innovative and highly specialized field, which will revolutionize the pharmaceutical industry in near future. Pharmaceutical nanotechnology presents revolutionary opportunities to fight against many diseases. It helps in detecting the antigen associated with diseases such as cancer, diabetes mellitus, neurodegenerative diseases, as well as detecting the microorganisms and viruses associated with infections. It is expected that in next 10 years market will be flooded with nanotechnology devised medicine.

Relevant Conferences:

13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; Pharmaceutical Development Conference April 24-26, 2017 Dubai, UAE; Pharmaceutical Technology Conference April 24-26, 2017 Dubai, UAE; Nanomedicine Conference May 29-31, 2017 Osaka, Japan; Drug Delivery Conference May 29-31, 2017 Osaka, Japan; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; Partnerships in Drug Delivery October 19-20, 2017 MA, USA; International Symposium on Drug Delivery and Pharmaceutical Sciences March 09–10, 2017 Kyoto, Japan; Non-Invasive Delivery of Macromolecules Conference 2017 February 21-24 2017 Carlsbad, USA; 2nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (Nddte'17) April 4 - 6, 2017 Barcelona, Spain; 2nd European Conference on Pharmaceutics April 03-04, 2017 Krakow, Poland; Respiratory Drug Delivery 2017(RDD Europe 2017) April 25-28, 2017 Nice, France.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-8: Smart Drug Delivery Systems

Smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts of the body where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of a targeted drug delivery system is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages.

Targeted drug delivery systems have been developed to optimize regenerative techniques. The system is based on a method that delivers a certain amount of a therapeutic agent for a prolonged period of time to a targeted diseased area within the body. This helps maintain the required plasma and tissue drug levels in the body, thereby preventing any damage to the healthy tissue via the drug. The drug delivery system is highly integrated and requires various disciplines, such as chemists, biologists, and engineers, to join forces to optimize this system.

The global revenue for advanced drug delivery systems is estimated to be $151.3 billion in 2013. In 2018, revenues are estimated to reach nearly $173.8 billion, demonstrating a compound annual growth rate (CAGR) of 2.8%.

Relevant Conferences:

13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; Pharmaceutical Development Conference April 24-26, 2017 Dubai, UAE; Pharmaceutical Technology Conference April 24-26, 2017 Dubai, UAE; Nanomedicine Conference May 29-31, 2017 Osaka, Japan; Drug Delivery Conference May 29-31, 2017 Osaka, Japan; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; Partnerships in Drug Delivery October 19-20, 2017 MA, USA; International Symposium on Drug Delivery and Pharmaceutical Sciences March 09–10, 2017 Kyoto, Japan; Non-Invasive Delivery of Macromolecules Conference 2017 February 21-24 2017 Carlsbad, USA; 2nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (Nddte'17) April 4 - 6, 2017 Barcelona, Spain; 2nd European Conference on Pharmaceutics April 03-04, 2017 Krakow, Poland; Respiratory Drug Delivery 2017(RDD Europe 2017) April 25-28, 2017 Nice, France.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-9:  Biomaterials in Drug Delivery

Biomaterials are any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. Biomaterials  can be derived either from nature or synthesized in the laboratory using a variety of chemical approaches utilizing metallic components, polymers, ceramics or composite materials. They are often used and/or adapted for a medical application, and thus comprise whole or part of a living structure or biomedical device which performs, augments, or replaces a natural function. Such functions may be benign, like being used for a heart valve, or may be bioactive with a more interactive functionality such as hydroxy-apatite coated hip implants. Biomaterials are also used every day in dental applications, surgery, and drug delivery. For example, a construct with impregnated pharmaceutical products can be placed into the body, which permits the prolonged release of a drug over an extended period of time. A biomaterial may also be an autograft, allograft or xenograft used as a transplant material. Pharmaceutica 2017 have penetrated into the biomaterials realm and hence a biomaterials conference.

Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017 at a compound annual growth rate (CAGR) of 5.3%.

Relevant Conferences:

2nd Biomaterials Conference March 27-28, 2017 Madrid, Spain; 2nd World Congress on Polymer Science and Engineering May 08-09, 2017 Barcelona, Spain; 10th Emerging Materials and Nanotechnology Conference July 27-29, 2017 Vancouver, Canada; 3rd Polymer Science and Engineering Conference October 02-04, 2017 Chicago, USA; Advanced Materials and Nanotechnology Conference October 26-28, 2017 Osaka, Japan; 28th Annual Meeting of the European Society for Biomaterials September 04-08, 2017 Athens, Greece; Society for Biomaterials 2017 Annual Meeting April 04-08, 2017 Minneapolis, USA; International Conference on Advances in Bio-Materials and Their Applications August 31-September 1 2017 London, UK; 3rd International Symposium on Biomaterials & Biosensors (BIOMATSEN 2017) April 22-26, 2017 Turkey; IASTED International Conference on Biomaterials and Tissue Engineering (BTE 2017) February 20-22, 2017 Innsbruck, Austria.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-10: Vaccine Drug Delivery Systems

Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Delivery of antigens from oil-based adjuvants such as Freunds adjuvant lead to a reduction in the number of doses of vaccine to be administered but due to toxicity concerns like inductions of granulomas at the injection site, such adjuvants are not widely used. FDA approved adjuvants for human uses are aluminium hydroxide and aluminium phosphate in the form of alum. Hence, search for safer and potent adjuvants resulted in the formulation of antigen into delivery systems that administer antigen in particulate form rather than solution form.

Other reasons driving the development of vaccines as controlled drug delivery systems are as follows:

  • Immunization failure with conventional immunization regimen involving prime doses and booster doses, as patients neglect the latter. Vaccines delivery systems on the other hand:
  • Allow for the incorporation of doses of antigens so that booster doses are no longer necessary as antigens are released slowly in a controlled manner.
  • Control the spatial and temporal presentation of antigens to the immune system there by promoting their targeting straight to the immune cells.

The global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging was $219.9 billion in 2012. This market is estimated to reach $242.2 billion in 2013 and $374.8 billion by 2018, a five-year compound annual growth rate (CAGR) of 9.1%.

Relevant Conferences:

18th Vaccine Adjuvants Conference April 24-26, 2017 Las Vegas, USA; 18th Vaccine Delivery Technologies Conference April 24-26, 2017 Las Vegas, USA; 17th Cancer Therapeutics and Vaccines Conference April 24-26, 2017 Las Vegas, USA; 28th World Congress on Vaccines October 26-28, 2017 Paris, France; 21st International Conference on Vaccine Design, Production & Safety August 21-22, 2017 Birmingham, UK; World Vaccine Congress 2017 April 10-12, 2017 Washington, USA; 2017 Florida Immunization Summit February 02-04, 2017 Florida, USA; 20th Annual Conference on Vaccine Research April 24-26, 2017 North Bethesda, MD; BIT’s 9th Annual World Congress of Vaccine (WCV-2017) March 29-31, 2017 Beijing, China; 6th Asian Vaccine Conference (ASVAC 2017) April 27-29, 2017 Singapore, Singapore; 2017 National Adult and Influenza Immunization Summit May 09-11, 2017 Atlanta, Georgia.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-11: Medical Devices for Drug Delivery

A medical device is any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic purposes and necessary for its proper application, intended by the manufacturer to be used for human beings for the purpose of:

·         Diagnosis, prevention, monitoring, treatment or alleviation of disease;

·         Diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap;

·         Investigation, replacement or modification of the anatomy or of a physiological process;

Medical devices vary according to their intended use and indications. Examples range from simple devices such as tongue depressors, medical thermometers, and disposable gloves to advanced devices such as computers which assist in the conduct of medical testing, implants, and prostheses. The design of medical devices constitutes a major segment of the field of mechanical engineering. Pharmaceutica 2017 is considered to be a medical devices conference.

The drug-device combination market is not fragmented and the key players in this market are Medtronic, Boston Scientific Corp., Edwards Life sciences Corp., Stryker Corp., QLT Inc. etc. The maximum number of new product developments is expected to take place in the bone graft substitutes, advanced wound care products and antimicrobial catheter markets. Our patent analysis indicates that E.U. has filed for the maximum number of patents followed by the U.S.

Relevant Conferences:

13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; Pharmaceutical Development Conference April 24-26, 2017 Dubai, UAE; Pharmaceutical Technology Conference April 24-26, 2017 Dubai, UAE; Nanomedicine Conference May 29-31, 2017 Osaka, Japan; Drug Delivery Conference May 29-31, 2017 Osaka, Japan; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; The 10x Medical Device Conference May 01-03, 2017 San Diego, USA; 2017 Design of Medical Devices Conference April 10, 11-13, 2017 Minneapolis, MN; 3rd Annual Compliance Online Medical Device Summit 2017 June 8-9, 2017 Boston, MA; Outsourcing in Clinical Trials Medical Devices 2017 June 27-28, 2017 Santa Clara, CA; BIOMEDevice Boston May 03-04, 2017 Boston, MA; Medtec Europe 4 - 6 April 2017 Messe Stuttgart, Germany.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-12: Peptides and Protein Drug Delivery

Peptides and proteins have great potential as therapeutics. Peptides can be designed to target a broad range of molecules, giving them almost limitless possibilities in fields such as oncology, immunology, infectious disease and endocrinology. While the peptide and protein therapeutic market has developed significantly in the past decades, delivery has limited their use. Although oral delivery is preferred, most are currently delivered intravenously or subcutaneously due to degradation and limited absorption in the gastrointestinal tract. Therefore, absorption enhancers, enzyme inhibitors, carrier systems and stability enhancers are being studied to facilitate oral peptide delivery. Additionally, transdermal peptide delivery avoids the issues of the gastrointestinal tract, but also faces absorption limitations. Due to proteases, opsonization and agglutination, free peptides are not systemically stable without modifications.

Currently, the market for peptide and protein drugs is estimated to be greater than US$40 billion/year, or 10% of the pharmaceutical market. This market is growing much faster than that of small molecules, and will make up an even larger proportion of the market in the future. At present there are over 100 approved peptide-based therapeutic drugs on the market, with the majority being smaller than 20 amino acids. Compared with the typical small-molecule drugs that currently make up the majority of the pharmaceutical market, peptides and proteins can be highly selective as they have multiple points of contact with their target. Increased selectivity may also result in decreased side effects and toxicity.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex.

Relevant Conferences:

13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; Pharmaceutical Development Conference April 24-26, 2017 Dubai, UAE; Pharmaceutical Technology Conference April 24-26, 2017 Dubai, UAE; Nanomedicine Conference May 29-31, 2017 Osaka, Japan; Drug Delivery Conference May 29-31, 2017 Osaka, Japan; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 4th Annual Peptides Congress 24-25 April 2017, London, UK; 12th Australian Peptide Conference October 15-19, 2017 Queensland, Australia; 25th American Peptide Symposium June 17-22, 2017 British Columbia, Canada; 10th Annual Proteins & Antibodies Congress 24-25 April 2017, London, UK; 5th Annual Macrocyclic and Constrained Peptides April 25-26, 2017 USA; TIDES: Oligonucleotide and Peptide Therapeutics April 30 - May 3, 2017 San Diego, CA.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.

Track-13: Global Drug Delivery Policy

The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S. constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% for 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists.

Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, quality control, and business development Business opportunities in drug deliveryPharmaceutical conferences offer unparalleled opportunities to establish new business relationships with companies from 40 countries through pre-scheduled one-on-one meetings with decision makers.

Relevant Conferences:

13th Pharmaceutical Nanotechnology Conference July 24-25, 2017 Rome, Italy; Pharmaceutical Development Conference April 24-26, 2017 Dubai, UAE; Pharmaceutical Technology Conference April 24-26, 2017 Dubai, UAE; Nanomedicine Conference May 29-31, 2017 Osaka, Japan; Drug Delivery Conference May 29-31, 2017 Osaka, Japan; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 4th Annual Peptides Congress 24-25 April 2017, London, UK; 12th Australian Peptide Conference October 15-19, 2017 Queensland, Australia; 25th American Peptide Symposium June 17-22, 2017 British Columbia, Canada; 10th Annual Proteins & Antibodies Congress 24-25 April 2017, London, UK; 5th Annual Macrocyclic and Constrained Peptides April 25-26, 2017 USA; TIDES: Oligonucleotide and Peptide Therapeutics April 30 - May 3, 2017 San Diego, CA.

Related Societies:

Controlled Release Society-CRS; Society of Biomaterials; International Society of Drug Delivery Sciences and Technology-APGI; Japan Society of Drug Delivery System; Oral Drug Delivery Focus Group; The Aerosol Society; Parenteral Drug Association-PDA; American Association of Pharmaceutical Scientists-AAPS; International Pharmaceutical Federation-FIP; Inhalation Drug Delivery Association-IDDA.





About Conference

Conference Series LLC is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe.

After a successful conference of Pharmaceutica 2016Conference Series LLC is currently bringing forth "10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems (Pharmaceutica 2017) slated on March 13-15, 2017 at London, UK. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutics and Novel Drug Delivery Systems.

2017 Highlights:

  • 300+ Participation (70% Industry: 30% Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Exhibition:

Why exhibit?

  • Make sales
  • Debut new products
  • Profile your brand
  • Meet new business partners and suppliers
  • Develop key relationships
  • Educate healthcare, pharma and biotech institutions and academia

Who you will meet?

Leaders in:

  • Drug Delivery
  • Formulation
  • Drug Development
  • Nanotechnology
  • QbD
  • Delivery Devices
  • Bioavailability
  • New Products
  • Pre-Formulation
  • Process R&D
  • CMC
  • Stability
  • Bio manufacturing
  • Manufacturing
  • Solid State Chemistry
  • Analytical Development
  • Product Enhancement

Who should sponsor?

  • Analytical Services
  • Formulation Development
  • CMO
  • Drug Delivery Technologies
  • Full service CRO
  • Preformulation testing
  • Software

Why you should attend?

  • Get to the heart of why formulation and delivery strategies fail. Dissect the challenges before looking for concrete solutions.
  • Discover how advances in the sector are impacting both large and small molecule drugs.
  • Explore tried and tested routes to improve bioavailability.
  • Understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set.
  • Discover the latest innovations in drug delivery devices.
  • Be inspired by innovative case studies and realise the potential impact on your formulation or delivery processes.
  • Engage in the exciting event format, with round tables, panels, showcases, speed networking and multiple conference tracks.
  • Share experiences, insights and strategies in interactive peer-to peer round tables.
  • Hear more perspectives in one place – from large medium and small organisations from pharma, biotech and academia.
  • Discover how scientific formulation advancements are being implemented in practice.
  • Get to the heart of why formulation and delivery strategies fail. Dissect the challenges before looking for concrete solutions.




Market Analysis

Title: 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

Date & Venue: March 13-15, 2017 London, UK

Theme: De novo in Drug Delivery Systems

Summary of Pharmaceutica 2017 Conference:-

Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.

Scope and Importance:-

Pharmaceutics is the discipline of pharmacy that deals with the process of turning a new chemical entity (NCE) or old drugs into a medication to be used safely and effectively by patients. It is also called the science of dosage form design. There are many chemicals with pharmacological properties, but need special measures to help them achieve therapeutically relevant amounts at their sites of action. Pharmaceutics helps relate the formulation of drugs to their delivery and disposition in the body. Pharmaceutics deals with the formulation of a pure drug substance into a dosage form. Branches of pharmaceutics include:

  • Pharmaceutical formulation
  • Pharmaceutical manufacturing
  • Dispensing pharmacy
  • Pharmaceutical technology
  • Physical pharmacy
  • Pharmaceutical jurisprudence

About Venue:

London is the capital and most populous city of England and the United Kingdom. Standing on the River Thames in the south east of Great Britain, London has been a major settlement for two millennia. It was founded by the Romans, who named it Londinium. London's ancient core, the City of London, largely retains its 1.12-square-mile (2.9 km2) medieval boundaries and in 2011 had a resident population of 7,375, making it the smallest city in England. Since at least the 19th century, the term London has also referred to the metropolis developed around this core. The bulk of this conurbation forms Greater London, a region of England governed by the Mayor of London and the London Assembly. The conurbation also covers two English counties: the small district of the City of London and the county of Greater London. The latter constitutes the vast majority of London, though historically it was split between Middlesex (a now abolished county), Essex, Surrey, Kent and Hertfordshire.

London is a leading global city, with strengths in the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism, and transport all contributing to its prominence. It is one of the world's leading financial centres and has the fifth-or sixth-largest metropolitan area GDP in the world depending on measurement. London is a world cultural capital. It is the world's most-visited city as measured by international arrivals and has the world's largest city airport system measured by passenger traffic. London is the world's leading investment destination, hosting more international retailers and ultra-high net-worth individuals than any other city. London's 43 universities form the largest concentration of higher education institutes in Europe, and a 2014 report placed it first in the world university rankings. According to the report London also ranks first in the world in software, multimedia development and design, and shares first position in technology readiness. In 2012, London became the first city to host the modern Summer Olympic Games three times.

London has a diverse range of peoples and cultures, and more than 300 languages are spoken within Greater London. The Office for National Statistics estimated its mid-2014 population to be 8,538,689, the largest of any municipality in the European Union, and accounting for 12.5 percent of the UK population. London's urban area is the second most populous in the EU, after Paris, with 9,787,426 inhabitants according to the 2011 census. The city's metropolitan area is one of the most populous in Europe with 13,879,757 inhabitants, while the Greater London Authority states the population of the city-region (covering a large part of the south east) as 22.7 million. London was the world's most populous city from around 1831 to 1925.

Societies Associated with Pharmaceutical Research:-

City Statistics:-

London

  • Royal Pharmaceutical Society (RPS)
  • British Pharmacological Society
  • Academy of Pharmaceutical Sciences
  • Royal Society of Chemistry

Country wise Statistics:-

UK

  • Association of the British Pharmaceutical Industry (ABPI)
  • Bandolier
  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • British Pharmacopoeia Commission (BPC)
  • Cochrane Collaboration
  • Commission on Human Medicines
  • Department of Health (DoH)
  • DrugScope
  • General Pharmaceutical Council (GPhC)
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Institute for Health and Clinical Excellence (NICE)
  • National Patient Safety Agency (NPSA)
  • NHS Confederation
  • Pharmaceutical Services Negotiating Committee (PSNC)
  • Pharmaceutical Society of Northern Ireland
  • Pharmacists' Defence Association (PDA)
  • Royal Pharmaceutical Society (RPS)
  • Scottish Medicines Consortium (SMC)
  • UK Clinical Pharmacy Association
  • UKMedix (UKM)
  • Worshipful Society of Apothecaries of London
  • Veterinary Medicines Directorate

Worldwide Statistics:-

International

  • International Pharmaceutical Federation (FIP)
  • International Pharmaceutical Students' Federation (IPSF)
  • European Association of Employed Community Pharmacists in Europe (EPhEU)
  • European Pharmaceutical Union (EPU)
  • Pharmaceutical Group of the European Union (PGEU)
  • Australian College of Pharmacy
  • Pharmaceutical Society of Australia
  • The Pharmacy Guild of Australia
  • The Society of Hospital Pharmacists of Australia
  • Canadian Pharmacists Association
  • Canadian Society of Hospital Pharmacists
  • Chinese Pharmaceutical Association
  • Danish Association of Pharmaconomists
  • Indian Pharmacist Association
  • Pharmaceutical Society of Ireland
  • The Pharmaceutical Association of Israel
  • Kuwait Pharmaceutical Association
  • Pharmaceutical Association of Mauritius
  • Pharmaceutical Society of New Zealand
  • Norwegian Pharmacy Association
  • Pakistan Pharmacists Association
  • National Pharmacy Association
  • Pharmaceutical Society of Northern Ireland
  • Royal Pharmaceutical Society (RPS)
  • American Association of Colleges of Pharmacy (AACP)
  • American Pharmacists Association (APhA)
  • American Society for Pharmacy Law
  • American Society of Consultant Pharmacists (ASCP)
  • American Society of Consultant Pharmacists Foundation
  • American Society of Health-System Pharmacists (ASHP)
  • Professional Compounding Centers of America
  • American College of Clinical Pharmacy (ACCP)

Statistical Representation:-

Industries Associated with Pharmaceutical Research:-

List of Pharmaceutical Companies in London:

List of Pharmaceutical Companies in UK:

List of Pharmaceutical Companies in the World:

Statistical Representation:-

Market Value on Pharmaceutical Research:-

Country Statistics:-

Top 10 pharmaceutical companies based on European prescription drug revenues in 2014 (in billion U.S. dollars)

This statistic depicts the top ten pharmaceutical companies based on prescription drug revenues in Europe in 2014. In that year, GlaxoSmithKline generated 8.1 billion U.S. dollars of prescription drug revenue in Europe. Global prescription drug sales are expected to reach about one trillion U.S. dollars by 2020. There is an increasing growth in sales of biological products.

Worldwide Statistics:-

Top 20 pharmaceutical companies based on worldwide prescription drug revenues in 2014 (in million U.S. dollars)

The top pharmaceutical companies in the world are Novartis, Pfizer, and Sanofi, based on 2014 pharmaceutical revenues. The companies generated 51.3 billion U.S. dollars, 44.9 billion U.S. dollars, and 40 billion U.S. dollars, respectively, in the year 2014.

Pharmaceutical companies are best known for manufacturing pharmaceutical drugs. These drugs have the aim to diagnose, to cure, to treat, or to prevent diseases. The pharmaceutical sector represents a huge industry, with the global pharmaceutical market being worth nearly one trillion U.S. dollars. The best known top global pharmaceutical players are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Most of these companies are involved not only in pure pharmaceutical business, but also manufacture medical technology and consumer health products, vaccines, etc. For example, Johnson & Johnson makes most of its revenues through medical devices, diagnostics and consumer health products.

Market Growth of Pharmaceutical Research in the last and upcoming ten years

Pharmaceuticals are one of the world's most profitable industries. During the last 30 years, the industry has spent billions of dollars on research and reaped billions in return. In 2008 alone, the pharmaceutical industry sold $773 billion in products worldwide-a number that has consistently grown for the past 8 years and is projected to increase again by 2.5 to 3.5 percent in 2017, according to the drug market research firm IMS Health.

But the process that turns research dollars into medicines is a slow and often arduous one. It now takes an average of 12 to 15 years and up to $1.7 billion for a drug to go from discovery to market, according to The Pharmaceutical Research and Manufacturers of America. And despite all the time and money invested, only a handful of drugs are approved by the FDA each year.

The arduous drug approval process reveals a central fact about Big Pharma: it's one of the most intensely regulated industries in the world. The U.S. Food and Drug Administration (FDA) and its European Union counterpart, the European Medicines Agency (EMEA), govern every aspect of a drug's development-from chemicals used in the drug and clinical study instructions, called protocols, to packaging components and marketing materials. This strict oversight is meant to protect patient safety, and pharma companies take regulatory oversight seriously. The constant pressure to adhere to government mandates shapes every aspect of a pharma firm's organization, operations, and culture. For example, drug companies maintain powerful regulatory affairs divisions-the departments that deal with government agencies-and they tend to be risk-averse.

Country Statistics:-

  • Growth in the EU5 is expected in the -1 to 2% range through 2016 compared to 3.8% for 2007-11, as national debt incurred due to the global economic crisis will be addressed through austerity programs and healthcare cost containment.
  • Limited savings from patent expires in the forecast period are prompting policy shifts to encourage greater use of generics and lower reimbursement, particularly in Spain.
  • Policies to examine the value newer medicines bring, when assessing their reimbursement prices, are being adopted in the UK with “value-based pricing” and in Germany with assessments under the AMNOG program.
  • Governments will take direct actions to control spending growth, or in some cases make real reductions, particularly in hospital spending.

Source: https://www.imshealth.com/deployedfiles/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/Global%20Use%20of%20Meds%202011/Medicines_Outlook_Through_2016_Report.pdf

Products manufactured by the industry relating to Pharmaceutical Research:-

Funds allotted to Pharmaceutical Research:-

Worldwide:-

Pharma companies have traditionally funded their internal R&D efforts totally on their own by investing 15% or more of their top line revenues to pay for these endeavours’. In addition, in order to tap into R&D going on outside their companies, pharma has financially supported external R&D efforts in deals with small biotech companies, research institutes, and universities. In fact, as funding for agencies like the NIH has stagnated over recent years, pharma has become an important source of funds to support early stage research.

Despite R&D budgets in the billions of dollars, pharma is now seeking to supplement their internal R&D investments with outside funding. One source has been major foundations.  The recent Cystic Fibrosis Foundation investment of $58 million into Pfizer R&D to support new research into areas for this disease is a perfect example. The justification for such deals is that pharma companies have a proven R&D track record for delivering new medicines, and the foundations feel that, by tapping into these scientists, they can maximize their chances for getting breakthrough medications.

Now Pharma has found a new investor for its R&D efforts – the U.S. government. In what is being hailed as the a “first-of-its-kind” collaboration, GlaxoSmithKline (GSK) has entered into a potential $200 million antibiotics pact with the Biomedical Advanced Research and Development Authority (BARDA), a division of Health & Human Services (HHS), to develop drugs to fight antibiotic resistance and bioterrorism. HHS will provide $40 million for the first 18 months of the deal to develop several antibiotics in the GSK portfolio. The work will be monitored by a joint BARDA-GSK committee and, if warranted, the agreement can be renewed with HHS providing additional funding of up to a total of $200 million over 5 years.

Federal Agencies:-

  • Grants.gov
  • NIH Grants & Funding
  • USFDA
  • NSF Funding
  • USDA NIFA Grants
  • AHRQ Funding & Grants
  • PCORI Funding
  • DOD Grants
  • DARPA (Defense Advanced Research Projects Agency)

Non-Federal Research Associations and Foundations:

  • Agency for Healthcare Research & Quality (AHRQ)
  • National Pharmaceutical Council

Pharmacy research funding

  • Harold and Marjorie Moss Charitable Trust: - 
  • This charitable trust awards funds for pharmacy training at undergraduate, postgraduate and doctorate level.
  • The Leverhulme Trade Charities Trust:-
  • The Leverhulme Trade Charities Trust makes grants for the benefit of chemists, commercial travellers and grocers. Pharmacists are able to apply for undergraduate and postgraduate bursaries.
  • The National Pharmacy Association:-
  • The National Pharmacy Association Health Education Foundation offers a bursary intended to support community pharmacists who wish to develop their skills to undertake research relating to community pharmacy practice.
  • The United Kingdom Clinical Pharmacy Association:- 
  • The UKCPA offer a number of annual awards for various aspects of clinical practice, patient safety and IT.

Members Associated with Pharmaceutical Research:-

In regard to Industrial personnel:

Research Positions:-

  • Lab technician
  • Research Associate
  • Research Scientist

Clinical Development and medical Jobs:-

  • Clinical Research Physician
  • Clinical Research Associate
  • Regulatory Affairs Associate
  • Bio Statistician
  • Clinical Data Manager
  • Medical Science Liaison

Manufacturing and Quality Assurance Jobs:-

  • Process Engineer
  • Quality Control Analyst
  • Quality Assurance Specialist

Business Operations Jobs:-

  • Market research Analyst
  • Associate Product Manager
  • Product Manager
  • Strategy Director
  • Business Development Manager

Apart from the industrial personnel where most of the research work is done, other research communities include:-

  • Academicians include Student community.
  • Researchers include Post docs, Research Associates.
  • Scientists include Professors, Associate professors, and Assistant professor.
  • Industries include Presidents, CEO’s, and R&D Managers.

Statistical representation:-

Biliography:-

http://www.phrma.org/sites/default/files/pdf/2014_PhRMA_PROFILE.pdf

http://www.efpia.eu/uploads/Figures_2014_Final.pdf

http://www.ifpma.org/about-ifpma/members/associations.html

http://www.ezilon.com/business/biotechnology_and_pharmaceuticals/index.shtml

file:///C:/Users/pharmaceutica/Desktop/%E2%80%A2%20European%20prescription%20drug%20revenues%20by%20top%20company%202014%20_%20Statistic.html

http://www.wetfeet.com/articles/career-overview-pharmaceuticals

https://www.imshealth.com/deployedfiles/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/Global%20Use%20of%20Meds%202011/Medicines_Outlook_Through_2016_Report.pdf

http://www.aacp.org/resources/research/Pages/ResearchFundingOpportunities.aspx

http://www.forbes.com/sites/johnlamattina/2013/05/23/pharma-continues-to-seek-external-rd-funding-this-time-from-the-government/





Past Conference Report

Pharmaceutica 2016

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Pharmaceutica 2016 Conference the best ever!

The 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, hosted by the Conference Series LLC was held during March 07-09, 2016 at Melia Avenida America, Madrid, Spain based on the theme “Challenges and Advances in Novel Drug Delivery Systems". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Pharmaceutics and Drug Delivery Systems, who made this event a grand success.

Conference Series LLC expresses its gratitude to the conference Moderator, namely Dr. Volkmar Weissig for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Poster judges namely, Dr. Volkmar Weissig, Dr. Amiram Goldblum, and Dr. B B Barik.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Pre-formulation Considerations
  • Formulation Aspects for Various Routes
  • Recent Advances in Drug Delivery Technology
  • Drug Targeting
  • Nanotechnology in Drug Delivery Systems
  • Application of Nanotechnology
  • Major Challenges in Drug Delivery System
  • Physiological Considerations
  • Vaccine Drug Delivery Systems
  • Biotherapeutics-Drug Discovery and Development
  • Medical Devices for Drug Delivery
  • Smart Drug Delivery Systems
  • Delivery Methods for Peptides and Biologics
  • Global Drug Policy in Drug Delivery Technology
  • Entrepreneurs Investment Meet

Conference Series LLC offers its heartfelt appreciation to organizations such as CiMUSUniversity of Santiago de CompostelaMinistry of Health, KSA and our esteemed Media Partners (NIAFIPPharmaVisionBRECBentham ScienceThe Pharma Review), and other eminent personalities who supported the conference by facilitating the discussion forums. Conference Series LLC also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Pharmaceutica 2016, Conference Series LLC is proud to announce the "10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems" to be held during March 13-15, 2017 at London, UK.

Best Poster Awards:

  • David Veale, Reckitt Benckiser Health Care Ltd., UK
  • Nataliya Storozhylova, University of Santiago de Compostela, Spain
  • Shayan F Lahiji, Yonsei University, Republic of South Korea
  • Anton Aleksashkin, Lomonosov Moscow State University, Russia
  • Abdulaziz Al Mahallawi, Cairo University, Egypt
  • Mohamed Yehia Abouleish, American University of Sharjah, UAE
  • Ahlam Zaid Alkilani, Al-Zaytoonah University of Jordan, Jordan

For More details visit: http://novel-drugdelivery-systems.pharmaceuticalconferences.com/


Past Reports  Gallery  



Past Conference Report

Pharmaceutica 2015

We gratefully thank all our wonderful speakers, conference attendees, students, associations and exhibitors for making Pharmaceutica-2015 Conference the best ever!

Previous Pharmaceutica-2014 conference for the PHARMA sector was organised by OMICS International (that organizes highly notable Pharmaceutical conferences throughout the globe) in 2014 in San Antonio, USA. Since then an annual conference has been organised in various locations around the globe.

In 2015, the conference took a new direction, broadening its focus beyond the laboratories to cover all aspects of Pharmaceutics and Drug Delivery Systems. This has provided a unique opportunity for academic and industry-wide communication and collaboration and has positioned the conference as the annual Pharma premier event.

The 5th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, was held during March 16-18, 2015 at Crowne Plaza, Dubai, UAE based on the theme Exploring the Challenges in Pre & Post Formulations and Drug Delivery Systems". Benevolent response and active participation was received from the Editorial Board Members of International Journals along with scientists, researchers, students and leaders from various fields of Pharmaceutics and Drug Delivery Systems, who made this event a grand success.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

  • R N Saha, BITS Pilani Dubai Campus, UAE
  • Alex Nivorozhkin, Neo-Advent Technologies LLC., USA
  • Khaled Mohamed Hosny, King Abdulaziz University, Kingdom of Saudi Arabia
  • Peter Karpinski, Novartis Pharmaceuticals Corp., USA
  • Husam M Younes, Qatar University, Qatar
  • B B Barik, Jazan University, KSA

Pharmaceutica-2015 offers its heartfelt appreciation to organizations such as Dubai Pharmacy CollegeSpanish Association of Pharmaceutical Industry and esteemed organizations, obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums and took privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.


Past Reports  Gallery  



Past Conference Report

Pharmaceutica-2014

On March 24-26, 20144th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems was scheduled at Hilton San Antonio Airport, USA. This conference was endeavoured to strengthen the future of the Novel Drug delivery Systems with Scientists’ Pharmacists, Researchers, Health care Professionals, University Professors, Industrialists, Pharmaceutical Associations, Editorial Board Members of International journals, and students.

The keynote speakers for the conference were: 

  • Panayiotis P Constantinides, Biopharmaceutical & Drug Delivery Consulting, USA, 
  • Jason Vaughn, Patheon Pharmaceuticals, USA, 
  • Tejraj M Aminabhavi, Soniya College of Pharmacy, India,
  • Gjumrakch Aliev, GALLY International Biomedical Research Consulting LLC, USA,
  • Konstantin Tsinman, Pion Inc., USA 
  • Walter Rudzuski, Texas State University, USA.

The keynote sessions, invited lectures by honourable guests, and all the other sessions highlighted the current challenges, issues, opportunities, innovations and ideas, in pharmaceutical research, that was reflected by the theme of the conference Pre-formulation, Formulation, and Physiology; Approaches for Drug Delivery Systems."  

This gave a rewarding learning environment to all the attendees.

Pharmaceutica” is known for uplifting the future of pharmacy by encouraging students and fellow researchers to present their work through poster presentations. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the pharmacy research.

The Best Poster Awardee was:

Dorota Watrobska-Swietlikowska, The Medical University of Gdansk.

Pharmaceutica knowledge all the organizing committee members, chair and co-chair, editorial board members of International journals, speakers, students, sponsors, exhibitors and media partners in making this event a great success.

Thank you to everyone for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Pharmaceutical research.


Past Reports  Gallery  



Past Conference Report

Pharmaceutica-2013

On April 8-10, 20133rd International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems was scheduled at Chicago/Northbrook, USA organized the . This conference was endeavoured to strengthen the future of the Pharmacy profession together with Pharmacists, Researchers, Health care Professionals, University Professors, Industrialists, Pharmaceutical Associations, Editorial Board Members of International journals, and students.

The keynote speakers for the conference were: 

  • Panayiotis P. Constantinides, Biopharmaceutical & Drug Delivery Consulting, USA
  • Wei-Chiang Shen, University of Southern California, USA
  • Kevin J. Filipski, Pfizer Worldwide Research & Development, USA 
  • Giancarlo Morelli, University of Naples, Italy 
  • David J. Brayden, University College Dublin, Ireland

The keynote sessions, invited lectures by honourable guests, and all the other sessions highlighted the current challenges, issues, opportunities, innovations and ideas, in pharmaceutical research, that was reflected by the theme of the conference Novel Advances in Pharmaceutical R&D."  

This gave a rewarding learning environment to all the attendees.

“Pharmaceutica” is known for uplifting the future of pharmacy by encouraging students and fellow researchers to present their work through poster presentations. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the pharmacy research.

The best poster awardees were: 

  • Srinath Muppalaneni
  • Mohsen A. Bayomi
  • Povilas Norvaisas
  • Padmakanthan Santha Raghu

Pharmaceutica wishes to acknowledge all the organizing committee members, chair and co-chair, editorial board members of International journals, speakers, students, sponsors, exhibitors and media partners in making this event a great success. 

Thank you everyone for the enormous exquisite response. This inspires us to continue organizing events and conferences for accelerating the Pharmaceutical research.


Past Reports  Gallery  



Past Conference Report

Pharmaceutica-2012

The 2nd International Conference on Pharmaceutics & Novel Drug Delivery Systems, was held on February 20-22, 2012 in San Francisco, USA. Generous response and active participation received from the Researchers, Leaders from Pharma, Government Organizations, Principal Investigators from Editorial Board Members of International Journals helped in making this meeting an ostentatious success.

Keynote presentations at the conference were:

  • Maryse Picher, Nova Language Services, USA
  • Sihong Song, University of Florida, USA
  • Handan He, Novartis Pharmaceuticals Corporation, USA
  • Roderick A. Slavcev, University of Waterloo, Canada
  • William H. Frey II, University of Minnesota, USA

These sessions were very prolific to the scientific community and they lifted up solutions and illustrated a way on the theme "To showcase the cutting edge technologies in Pharmaceutics & Strategies of Drug Delivery"

We found more energetic contribution from scientists, researchers and principal investigators. Presentations during these sessions was excellent, it was established a new prospect and hopes on on-going projects in Pharmaceutics and novel delivery systems.


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date March 13-15, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Testimonials

Conferenceseries Destinations